Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Sural (Ethambutol) is used to treat pulmonary tuberculosis. It should not be the only antituberculous drug a patient takes. It must be given together with at least one other antituberculous drug. The companion drug is chosen on the basis of clinical experience, comparative safety, and appropriate in vitro susceptibility studies. For patients who have not had antituberculous treatment before, meaning initial treatment, the regimens used most often have been Sural plus isoniazid, and Sural plus isoniazid plus streptomycin. Patients who have already received antituberculous treatment often have mycobacteria that are resistant to the other drugs used in initial therapy. So in these retreatment patients, Sural should be combined with at least one second line drug that the patient has not taken before, and to which susceptibility has been shown by appropriate in vitro studies. The antituberculous drugs given alongside Sural have included cycloserine, ethionamide, pyrazinamide, viomycin and others. Isoniazid, aminosalicylic acid and streptomycin have also been used in multiple drug regimens. Alternating drug regimens have been used as well.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Ethambutol appears to block the making of 1 or more metabolites in susceptible bacteria. Without them, the cell's metabolism is impaired, the bacteria stop multiplying, and the cells die. The medicine acts on susceptible bacteria only while they are dividing.

Pregnancy & Breastfeeding

Pregnancy Category C. This means that either animal studies have shown some risk to the developing baby (such as birth defects or fetal loss), but no well-controlled studies exist in pregnant women, or no adequate studies have been done in either women or animals. Because of this uncertainty, ethambutol should be used during pregnancy only if the potential benefit to the mother is judged to outweigh the potential risk to the unborn child.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Ethambutol should never be used alone, whether it's initial treatment or retreatment. It should be given once every 24 hours only. Absorption is not significantly altered by taking it with food. In general, therapy should continue until bacteriological conversion has become permanent and maximal clinical improvement has occurred. Ethambutol is not recommended for pediatric patients under thirteen years of age, because safe conditions for use have not been established. Initial Treatment For patients who have not had antituberculous therapy before, give Ethambutol 15 mg/kg of body weight as a single oral dose once every 24 hours. In the more recent studies, isoniazid was given at the same time, as a single daily oral dose. Retreatment For patients who have already had antituberculous therapy, give Ethambutol 25 mg/kg of body weight as a single oral dose once every 24 hours. At the same time, give at least one other antituberculous drug to which the organisms have been shown to be susceptible by appropriate in vitro tests. Suitable drugs are usually those the patient has not used before. After 60 days of Ethambutol, reduce the dose to 15 mg/kg of body weight, still as a single oral dose once every 24 hours. During the period when a patient is on the daily dose of 25 mg/kg, monthly eye examinations are advised. Renal Impairment The dose may need adjusting, as determined by blood levels of ethambutol.

Side Effects & Interactions